The September 2 issue of JNCI features articles on nonmelanoma skin cancer and the risk for subsequent cancers, antihypertensive agents and chemoprevention of skin cancer, a potential anticancer drug from sea sponges, a mouse model for leukemia pathogenesis, and renal cell carcinoma risk associated with a mutation in a gene encoding a mitochondrial enzyme.
